Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

SYF2 Suppression Mitigates Neurodegeneration in Models of Diverse Forms of ALS

ABSTRACT: SYF2 Suppression Mitigates Neurodegeneration in Models of Diverse Forms of ALS

PROVIDER: PRJNA902285 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR22309814_1.fastq.gz	Fastqsanger.gz
	SRR22309814_2.fastq.gz	Fastqsanger.gz
	SRR22309815_1.fastq.gz	Fastqsanger.gz
	SRR22309815_2.fastq.gz	Fastqsanger.gz
	SRR22309816_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 30

Similar Datasets

SYF2 Suppression Mitigates Neurodegeneration in Models of Diverse Forms of ALS

Project description:RNA sequencing analysis of human induced motor neurons generated from a C9ORF72 ALS patient line and its isogenic control, treated with siRNA targetting SYF2. The goal of this study is to evaluate the process of SYF2 suppression in rescuing ALS motor neuron degeneration.

2022-11-23 | GSE218079 | GEO

PIKFYVE Inhibition Mitigates Disease in Models of Diverse Forms of ALS

Project description:PIKFYVE Inhibition Mitigates Disease in Models of Diverse Forms of ALS

| PRJNA912584 | ENA

SYF2 suppression mitigates neurodegeneration in models of diverse forms of ALS.

Project description:Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease caused by many diverse genetic etiologies. Although therapeutics that specifically target causal mutations may rescue individual types of ALS, such approaches cannot treat most patients since they have unknown genetic etiology. Thus, there is a critical need for therapeutic strategies that rescue multiple forms of ALS. Here, we combine phenotypic chemical screening on a diverse cohort of ALS patient-derived neurons with bioinformatic analysis of large chemical and genetic perturbational datasets to identify broadly effective genetic targets for ALS. We show that suppressing the gene-encoding, spliceosome-associated factor SYF2 alleviates TDP-43 aggregation and mislocalization, improves TDP-43 activity, and rescues C9ORF72 and causes sporadic ALS neuron survival. Moreover, Syf2 suppression ameliorates neurodegeneration, neuromuscular junction loss, and motor dysfunction in TDP-43 mice. Thus, suppression of spliceosome-associated factors such as SYF2 may be a broadly effective therapeutic approach for ALS.

| S-EPMC10062011 | biostudies-literature

PIKFYVE Inhibition Mitigates Disease in Models of Diverse Forms of ALS [1]

Project description:PIKFYVE Inhibition Mitigates Disease in Models of Diverse Forms of ALS [1]

| PRJNA912588 | ENA

PIKFYVE Inhibition Mitigates Disease in Models of Diverse Forms of ALS [2]

Project description:PIKFYVE Inhibition Mitigates Disease in Models of Diverse Forms of ALS [2]

| PRJNA912589 | ENA

PIKFYVE Inhibition Mitigates Disease in Models of Diverse Forms of ALS [1]

Project description:RNA sequencing analysis of human iPSC-derived motor neurons generated from one C9ORF72 ALS/FTD patient line, treated with DMSO or Apilimod. The goal of this study is to evaluate the effect of PIKFYVE inhibitor in rescuing ALS motor neuron degeneration.

2022-12-18 | GSE221015 | GEO

PIKFYVE Inhibition Mitigates Disease in Models of Diverse Forms of ALS [2]

Project description:RNA sequencing analysis of human iPSC-derived motor neurons generated from two C9ORF72 ALS/FTD patient lines, treated with negative control ASO (NC ASO) or PIKFYVE ASO. The goal of this study is to evaluate the effect of PIKFYVE suppression in rescuing ALS motor neuron degeneration.

2022-12-18 | GSE221016 | GEO

Glycolytic preconditioning in astrocytes mitigates trauma-induced neurodegeneration

Project description:Glycolytic preconditioning in astrocytes mitigates trauma-induced neurodegeneration

| PRJNA725513 | ENA

Glycolytic preconditioning in astrocytes mitigates trauma-induced neurodegeneration

Project description:Glycolytic preconditioning in astrocytes mitigates trauma-induced neurodegeneration

| PRJNA745569 | ENA

Reversing lysosome-mTORC1-ribosome axis dysregulations to mitigate C9FTD/ALS neurodegeneration [snRNA-Seq]

Project description:We report the application of snRNA-seq in the mouse cortex with C9FTD/ALS neurodegeneration

2023-06-30 | GSE206664 | GEO